Clinical Pipeline
Chronic Wound
| Stage | Timeline | ||
|---|---|---|---|
| KV23a | Calciphylaxis | Phase 3 | Projected Start Q2 2024 End 2027 |
| ” “ | ” “ | Phase 2 | Projected Start Q4 2024 End 2025 |
| ” “ | Chronic Ulcers | Phase 3 | Projected Start Q3 2026 End 2029 |
Non-prescription
| Stage | Timeline | ||
|---|---|---|---|
| VinSan | Burns (1st degree) | RWE | Safety and Stability Projected Start Q4 2022 |
Exploratory / RWE Preclinical or Real World Evidence
Phase 1 / 2 Safety & Efficacy
Phase 3 Clinical Relevance